search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Electronics


Quantum sensing could aid in better heart attack decision-making.


Heart of the matter


Roughly eight to ten million patients go to the emergency department complaining of chest pain each year in the US, Au-Yeung explains. Physicians are required to use an array of tests to identify whether a patient is experiencing a heart attack. Less than 10% of emergency department patients with chest pain experience heart attacks. “You can imagine that lots of the overcrowding in ERs is because the available tests the physicians use are imperfect. They have to do serial testing to gain confidence before they make a decision.” According to Au-Yeung, estimates suggest that approximately $10bn is spent annually in the US on chest pain evaluations, in part due to unnecessarily long ER stays. CardiAQ is designed for use in ERs after front-line test results have found conflicting results. This imaging modality will help inform diagnosis as an adjunct, says Au-Yeung, explaining that it offers an ultra-detailed and constantly updating map of the heart, compared with the limited stationary views provided by traditional imaging modalities. The technology features a proprietary electrically compact magnetometer sensor that detects minute variations in the heart’s magnetic signals. Advanced AI models are being developed to filter electromagnetic interference and classify complex magnetic field maps into a diagnosis. Data collected by the device is sent to the cloud, where a machine learning classifier analyses it. Clinical studies of the device’s efficacy are currently under way at the University of California, San Francisco (UCSF) and Mount Sinai West Medical Center in New York City. Unlike conventional MCG devices, CardiAQ is compact, operates at room temperature with low power requirements, and needs no specialised cooling or shielding. To Au-Yeung, quantum sensing tech in medical devices has the potential to dramatically change patient care in the future, especially if used in combination with burgeoning technologies like edge


58


AI, though other experts in the field believe edge AI is still somewhat over the horizon for broad use in quantum sensing medical devices.


Matters of the head


Medtech OEM FieldLine Medical is focused on providing neuroscientific tools that may eventually assist clinicians in studying and diagnosing neurological and mental health conditions through compact quantum sensing technology. Its HEDscan system is a wearable magnetoencephalography (MEG) device that uses a quantum magnetometer (OPM) sensor to passively record magnetic signals from the brain and nervous system.


“HEDscan is making MEG more accessible, wearable and scalable by replacing cryogenic sensors with room-temperature quantum sensors,” explains Dr Svenja Knappe, associate research professor at the University of Colorado and co-founder of FieldLine. Current MEG systems for brain scanning are out of reach for most hospitals and patients because they typically rely on large, multimillion-dollar cryogenic equipment with high operating expenses. Featuring a wearable smart helmet and non-cryogenic, room-temperature quantum sensors, HEDscan provides a more compact and potentially less expensive solution, and is currently available for research-only use, with clinical translation in the planning stages. “We are trying to address the mental health crisis and, if successful, we will democratise functional brain imaging and make it more accessible,” says Knappe. “We envision that it can be used for early screening, patient differentiation and treatment monitoring.” Knappe also predicts that AI will eventually play a large role in facilitating FieldLine Medical’s technology.


MEG studies brain activity by detecting neural oscillations and connectivity patterns that can be associated with neurological and psychiatric conditions such as schizophrenia, post-traumatic


www.medicaldevice-developments.com


Halfpoint/Shutterstock.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100